Diclofenac (DCLF) is a nonsteroidal anti-inflammatory drug that is associated with idiosyncratic adverse drug reactions in humans. Previous studies revealed a crucial role for intestinederived bacteria and/or lipopolysaccharide (LPS) in DCLF-induced hepatotoxicity. We further explored this mechanism by conducting gene expression analysis of livers from rats treated with a hepatotoxic dose of DCLF (100 mg/kg) with or without oral antibiotic pretreatment. Genes for which expression was altered by DCLF were divided into two groups: genes with expression altered by antibiotic treatment and those unaffected by antibiotics. The former group of genes represented the ones for which DCLF-induced alterations in expression depended on intestinal bacteria. The expression of the latter group of genes was probably changed by direct effect of DCLF rather than by intestinal bacteria. Functional analysis of genes in the former group revealed LPS-related signaling, further suggesting a role for bacterial endotoxin in the liver injury. Functional analysis of genes in the latter group revealed changes in signaling pathways related to inflammation, hypoxia, oxidative stress, the aryl hydrocarbon receptor, and peroxisome proliferator-activated receptor ␣. Neutrophil depletion failed to protect from DCLFinduced hepatotoxicity, suggesting that intestinal bacteria contribute to liver injury in a neutrophil-independent manner. Hypoxia occurred in the livers of rats treated with DCLF, and hypoxia in vitro rendered hepatocytes sensitive to DCLF-induced cytotoxicity. These results support the hypothesis that intestinal bacteria are required for DCLF-induced hepatotoxicity and suggest that hypoxia plays an important role in the pathogenesis.
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Diclofenac (DCLF) induces idiosyncratic hepatotoxicity in human patients with a low incidence but high severity (Banks et al., 1995; Boelsterli, 2003) . Cases of severe hepatic injury leading to liver transplantation comprise a large portion of the reported cases of DCLF-induced hepatotoxicity. Due to the lack of apparent dose dependence, the variable temporal relationship with drug exposure, and the lack of animal models, the mechanisms of DCLF-induced hepatic idiosyncratic adverse drug reactions (IADRs) remain largely unknown (Boelsterli, 2003) . Metabolic and kinetic factors (Seitz et al., 1998; Daly et al., 2007) , oxidative stress (Cantoni et al., 2003) , and mitochondrial injury (Masubuchi et al., 2002) have been suggested to be important to the pathogenesis, but these require further evaluation, especially in vivo. For instance, hepatocellular cytotoxicity from DCLF or its metabolites is only observed in vitro with large concentrations of DCLF that are not achieved in vivo (Masubuchi et al., 2002; Gómez-Lechón et al., 2003b) . Likewise, polymorphisms in enzymes that metabolize DCLF, such as UDP-glucuronosyltransferase 2B7 and CYP2C8, and in the DCLF glucuronide transporter, ABCC2, have been found in human patients who developed DCLF hepatotoxicity (Daly et al., 2007) . However, no direct evidence has emerged to support a causal relationship between DCLF metabolites and hepatotoxicity in vivo.
DCLF is known to cause intestinal ulceration that allows bacteria within the intestinal tract to translocate into the circulation (Kim et al., 2005; Deng et al., 2006) . Furthermore, antibiotics that eliminated gut-derived, Gram-negative bacteria attenuated hepatotoxicity induced by a large dose of DCLF (100 mg/kg) (Deng et al., 2006) . Previous studies showed that lipopolysaccharide (LPS) exposure interacted with a small, nontoxic dose of DCLF (20 mg/kg) to result in liver injury in rats (Deng et al., 2006) . These results suggested that bacteria or LPS exposure during DCLF treatment could be a susceptibility factor for DCLF-induced IADRs. Because such exposure during drug treatment could be episodic and occur irregularly in human patients , this could explain the variable dose and temporal relationships that characterize DCLF IADRs. LPS exposure also interacts with other IADR-producing drugs, such as trovafloxacin and ranitidine, to cause hepatocellular injury in animals Waring et al., 2006) .
The exact mechanisms by which bacteria or LPS contribute to DCLF-induced hepatotoxicity remain unknown. In accordance, the further exploration of factors contributing to toxicity that are evoked directly by DCLF and independent of bacteria/LPS is required. Here, we examined gene expression profiles in livers of DCLF-treated rats with or without antibiotic pretreatment to elucidate bacteria/LPS dependentand -independent pathways that are associated with DCLF hepatotoxicity.
Materials and Methods
Experimental Design. Rats received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences, and the procedures were approved by the Michigan State University Committee on Animal Use and Care. Male, Sprague-Dawley rats [Crl:CD (SD)IGS BR; Charles River Breeding Laboratories, Portage, MI] weighing 250 to 350 g were used for these studies. Animals were fed standard chow (Rodent chow/Tek 8640; Harlan Teklad, Madison, WI) and allowed access to water ad libitum. They were allowed to acclimate for 1 week in a 12-h light/dark cycle before use.
Rats were fasted for 16 h and then given a hepatotoxic dose of DCLF (100 mg/kg i.p.) or its vehicle saline. They remained fasted and were sacrificed 6 h after DCLF treatment for evaluation of liver injury, histopathology, and gene expression. The rats were anesthetized with sodium pentobarbital (50 mg/kg i.p.), blood was collected from the dorsal aorta, and a portion of the blood was placed into a tube containing sodium citrate (final concentration, 0.38%) for collection of plasma. Another portion was allowed to clot at room temperature, and serum was collected and stored at Ϫ80°C until use. Representative (3-4 mm) slices of the ventral portion of the left lateral liver lobe were collected and fixed in 10% neutral-buffered formalin and then later processed for histological evaluation. A portion of the right medial lobe of the liver was flash-frozen in liquid nitrogen for gene expression analysis.
Gut sterilization was achieved by treating rats with polymyxin B (150 mg/kg) and neomycin (450 mg/kg) orally for 4 days before treatment with DCLF as described previously (Deng et al., 2006) . This treatment has been shown to abolish completely the Gramnegative bacterial growth in rat fecal culture and to reduce plasma endotoxin concentration after chronic ethanol treatment (Adachi et al., 1995) . For comparison of expression changes in animals treated with LPS versus those treated with DCLF, rats were treated with a nonhepatotoxic dose of LPS (2.9 ϫ 10 7 EU/kg i.v.) or a nonhepatotoxic (20 mg/kg i.p.) or hepatotoxic (100 mg/kg i.p.) dose of DCLF. The rats were sacrificed 6 h after treatment, and RNA was prepared for microarray analysis.
Alanine Aminotransferase Activity and Histopathology Assessment. Hepatic parenchymal cell injury was estimated by quantifying serum alanine aminotransferase (ALT) activity, which was determined spectrophotometrically using Infinity-ALT from Thermo Fisher Scientific (Waltham, MA). Formalin-fixed liver samples were routinely processed and stained with hematoxylin and eosin. Slides were read by a pathologist (E.A.G.B.) blinded to the treatment.
RNA Preparation. Each frozen liver sample (approximately 100 mg of tissue) was immediately added to 2 ml of TRIzol reagent (Invitrogen, Carlsbad, CA) and homogenized using a Polytron 300D tissue grinder (Brinkmann Instruments, Westbury, NY). One milliliter of the tissue homogenate was transferred to a microcentrifuge tube, and total RNA was extracted with chloroform followed by nucleic acid precipitation with isopropanol. The pellet was washed with 80% ethanol and resuspended in molecular biology grade water. Nucleic acid concentration was determined spectrophotometrically at 260 nm (Smart-Spec; Bio-Rad, Hercules, CA), and RNA integrity was evaluated using an Agilent bioanalyzer (model 2100; Agilent Technologies, Santa Clara, CA).
Gene Array Analysis. Microarray analysis was performed using the standard protocol provided by Affymetrix (Santa Clara, CA). Approximately 5 g of total RNA was reverse-transcribed into cDNA using a Superscript II Double-Strand cDNA synthesis kit (Invitrogen) according to the manufacturer's instructions, with the exception that the primer used for the reverse transcription reaction was a modified T7 primer with 24 thymidines at the 5Ј end (Enzo Diagnostics, New York, NY). The sequence was 5Ј-GGCCAGTGAATTGTA-ATACGACTCACTATAGGGAGGCGG-(dT)24 -3Ј. cDNA was purified via phenol/chloroform/isoamylalcohol (Invitrogen) extraction and ethanol precipitation. The purified cDNA was resuspended in molecular biology-grade water. Biotin-labeled cRNA from the cDNA was synthesized according to the manufacturer's instructions using the Enzo RNA Transcript Labeling Kit (Affymetrix). The labeled cRNA was then purified using RNeasy kits (QIAGEN, Valencia, CA). Subsequently, cRNA concentration and integrity were evaluated. Approximately 20 g of cRNA was then fragmented in a solution of 40 mM Tris acetate, pH 8.1, 100 mM potassium acetate, and 30 mM magnesium acetate at 94°C for 35 min. Fragmented, labeled cRNA was hybridized to an Affymetrix rat genome RAE230A 2.0 array, which contained sequences corresponding to roughly 30,000 transcripts at 45°C overnight using an Affymetrix Hybridization Oven 640. The array was subsequently washed and stained twice with streptavidin-phycoerythrin (Invitrogen, Carlsbad, CA) using a GeneChip Fluidics Workstation 400 (Affymetrix). The array was then scanned using the Affymetrix GeneChip Scanner 3000.
The microarray scanned image and intensity files (.cel files) were imported into Rosetta Resolver gene expression analysis software version 7.1 (Rosetta Inpharmatics LLC, Seattle, WA). Error models were applied, and ratios were built for each treatment array versus its respective vehicle control (pooled in silico). A p value was calculated for every fold change using the Rosetta Resolver error model (Rajagopalan, 2003) .
Statistical Filtering of Genes Changed after DCLF Treatment. Genes with expression that changed after treatment with antibiotic/vehicle (Veh), Veh/DCLF, or antibiotic/DCLF were identified with Veh/Veh as baseline using the following criteria: p Ͻ 0.01 in at least two of three (antibiotic/Veh group) and at least four of five (Veh/DCLF group) and p Ͻ 0.01 in at least three of four animals (antibiotic/DCLF group). The genes for which expression changed after Veh/DCLF treatment were analyzed further. The genes in this group were examined for differential expression between Veh/DCLF and antibiotic/DCLF treatments. Genes were considered differentially expressed if they met the following criterion: p Ͻ 0.01 in at least three of four animals in the antibiotic/DCLF group using Veh/ DCLF as baseline. This analysis rendered two groups of genes: those expressed differently between Veh/DCLF and antibiotics/DCLF (bac-
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at ASPET Journals on April 3, 2017 jpet.aspetjournals.org teria-dependent genes) and those that were expressed similarly (bacteria-independent genes). These two groups of genes were further filtered by the criterion of degree of correlation of their expression level with plasma ALT activity. The gene expressions were considered highly correlated with ALT if the correlation coefficient was greater than 0.6. The function of genes with expression level highly correlated with ALT was identified as described in the Entrez Gene site (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dbϭgene).
Furthermore, these two groups of genes were imported into Ingenuity Pathway Analysis 5.5 (Ingenuity Systems, Redwood City, CA). This yielded a list of pathway terms ranked by their probability of over-representation or under-representation in a particular gene list. Functional annotations were based on the Ingenuity Systems knowledge base. Ratio refers to the percentage of the number of genes identified in a particular pathway found in the imported list of genes to the total number of genes in that particular pathway. The pathways reported by Ingenuity Pathway Analysis were ranked by a p value, which illustrates the deviation of the observed number of genes for each pathway found in the imported list of genes from the number expected to occur by chance.
Neutrophil Staining and Neutrophil Depletion. Neutrophils (PMNs) accumulated in liver were enumerated by immunohistochemical staining and quantified as described previously (Yee et al., 2003) . PMN depletion was accomplished by pretreating rats with a rabbit anti-rat PMN serum (Inter-Cell Technologies, Jupiter, FL) 16 h before DCLF treatment as described before (Luyendyk et al., 2005; Deng et al., 2007) . This PMN antiserum selectively reduces circulating PMNs (Luyendyk et al., 2005; Deng et al., 2007) .
Evaluation of Liver Hypoxia. Liver hypoxia was evaluated by immunohistochemical staining for pimonidazole (PIM) adducts. PIM is a 2-nitroimidazole marker of hypoxia and has been used to identify regions of hypoxia in liver. Unless otherwise noted, rats were given 120 mg/kg Hypoxyprobe-1 (PIM hydrochloride; Millipore Bioscience Research Reagents, Temecula, CA) intraperitoneally 2 h before they were killed. PIM adduct immunostaining was performed as described previously (Copple et al., 2004) . Quantification of immunostaining was performed using Scion Image Beta 4.0.2 software (Scion Corporation, Frederick, MD). Background was set to be the average pixel intensity in periportal regions of Veh/Veh-treated livers (i.e., an area where no hypoxia occurs). An increase in positive immunostaining for PIM-modified proteins indicates hypoxia in the liver tissue.
Effects of Hypoxia on DCLF-Induced Hepatocyte Death in Vitro. Primary hepatocytes were isolated from male Sprague-Dawley rats (Charles River Breeding Laboratories) weighing 150 to 170 g using the Invitrogen HPC Product Line (Invitrogen), including liver perfusion medium, collagenase-containing liver digest medium, and hepatocyte wash medium. All reagents were warmed to 37°C. Rats were anesthetized with sodium pentobarbital (50 mg/kg i.p.). The liver was perfused in situ through the portal vein with perfusion medium at a flow of 30 ml/min, followed immediately by collagenase digestion with liver digest medium at a flow of 20 ml/min, for 7 to 10 min. After digestion, the liver was removed from the rat's abdomen and rinsed in warmed phosphate-buffered saline, then transferred to a sterile Petri dish containing 5 ml of liver digest medium and 40 ml of hepatocyte wash medium. The digested liver was gently manipulated with sterile forceps to disperse the hepatocytes from the capsule, and the resulting cell homogenate was filtered through sterile nylon gauze to remove debris. The filtrate was centrifuged (100g, 30 s) and washed twice with hepatocyte wash medium, then resuspended in complete Williams' medium E (supplemented with 2 mM L-glutamine and 0.1% gentamicin) with 10% fetal bovine serum. Viability was assessed with trypan blue exclusion, and cells were plated if viability was greater than 85%. Cells were plated at a density of 2.5 ϫ 10 5 cells/ml in 12-well cell culture plates (Corning Life Sciences, Lowell, MA). Cells were allowed to adhere to the plates for 3 h before treatment. After this time, medium was refreshed to serum-free Williams' medium E, and cells were treated with DCLF. Plates were immediately transferred to hypoxic glove boxes (Coy Laboratory Products Inc., Grass Lake, MI) set at 5% oxygen and 5% CO 2 or incubators with room air (approximately 20% oxygen) controlled at 5% CO 2 . Eight hours later, the medium (including unattached cells) was collected. Attached cells were lysed with 1% Triton X-100 in phosphate-buffered saline. Medium and attached cell lysates were and centrifuged at 8000g for 4 min. Medium supernatant was removed, and the resulting unattached cell pellet was lysed with 1% Triton X-100.
The medium, unattached cell lysates, and attached cell lysates were assessed for ALT activity using Infinity-ALT reagent. ALT release was expressed as a percentage of the total ALT activity (activity in medium, unattached cells, and attached cell lysate) detected in the medium and unattached cell lysates.
Statistical Analysis. All data are expressed as mean Ϯ S.E.M. Two-way analysis of variance with Tukey's post hoc test was applied using SigmaStat 3.0 (Systat Software, Inc., San Jose, CA). One-way analysis of variance was applied with Tukey's post hoc test. The criterion for statistical significance was p Ͻ 0.05.
For microarray analysis, error models were applied, and ratios were built for each treatment array versus its averaged respective vehicle control (pooled in silico) using the Rosetta Resolver system. Gene expression was considered significantly changed if the p value was less than or equal to 0.01. Agglomerative cluster analysis was performed using the average link heuristic criteria and the Euclidean distance metric for similarity measure. K-means clustering was performed using cosine correlation as the metric type.
Results
Liver Histopathology. Our previous study showed that antibiotic pretreatment reduced the increase in serum ALT activity induced by DCLF treatment (100 mg/kg) (Deng et al., 2006) . In accordance, histopathology was examined 6 h after DCLF treatment. There were no apparent histopathological changes in Veh/Veh-or antibiotic/Veh-treated livers (data not shown). Histopathology revealed subcapsular hemorrhagic coagulative necrosis in Veh/DCLF-treated livers, and this was absent in livers from antibiotic/DCLF-treated rats (Fig. 1) .
Hierarchical Clustering of Hepatic Gene Expression Profiles. Hepatic gene expression profiles were examined 6 h after DCLF treatment. Hierarchical clustering was performed using Euclidian distance with Veh/Veh-treated rats as baseline. There were two major clusters: animals that were treated with DCLF and those that were not (Fig. 2) . In contrast, the antibiotic/DCLF-and Veh/DCLF-treated rats did not separate from each other.
K-Means Clustering of Hepatic Gene Expression Profiles. Nonsteroidal anti-inflammatory drugs such as DCLF can cause intestinal damage and thereby potentially expose the liver to bacteria or LPS. This coupled with the observation that pretreatment with antibiotics decreased DCLF-induced liver injury suggested that LPS might be involved in DCLF-mediated hepatotoxicity. To explore whether a hepatotoxic dose of DCLF induced gene expression changes similar to those induced by LPS, K-means clustering was performed on gene expression profiles 6 h after treatment with LPS (2.9 ϫ 10 7 EU/kg i.v.) or nontoxic (20 mg/kg) or toxic (100 mg/kg) doses of DCLF. K-means clustering inputting three distinct clusters corresponding to the three treatments (Fig. 3) revealed greater similarity between the gene expression profiles of the LPS group and the toxic DCLF dose group than between the nontoxic DCLF dose group and either of the other two groups.
RT-PCR Comparison with Gene Array Results.
Recent technological improvements have increased the reproducibility and reliability of microarray results (Raymond et al., 2006) . Most microarray results are now accurate, especially for highly regulated genes, and differences between microarray-and PCR-generated data occur mostly in the amplitude of the detected expression change (Rajeevan et al., 2001; Dallas et al., 2005; Bosotti et al., 2007) . Nevertheless, we conducted real-time PCR validation of some of the gene expression changes mentioned in the results section (Supplemental Data). The results showed strong agreement between the RT-PCR and microarray data, especially regarding the direction of change in expression.
Functional Analysis of Genes Altered by DCLF Treatment. Genes with expression altered by DCLF treatment relative to Veh/Veh controls were classified into two groups, those expressed differently after Veh/DCLF treatment compared with antibiotic/DCLF treatment and those expressed similarly after Veh/DCLF treatment and antibiotic/DCLF treatment. The former group consisted of gene expression changes associated with DCLF-induced liver injury and dependent on intestinal bacteria (bacteria-dependent genes), whereas the second group consisted of gene expression changes that were independent of intestinal bacteria (bacteria-independent genes).
The bacteria-dependent genes were further filtered by the criterion of degree of correlation with ALT. The genes highly correlated with ALT are shown in Table 1 . The function of genes with potential importance in liver injury was also noted. These genes include those inducible by LPS, such as fibrinogen and signal transducer and activator of transcription 3 (STAT3). Genes also emerged that are involved in fatty acid metabolism (e.g., aldehyde dehydrogenase 3a2 and acyl-CoA synthetase long-chain family jpet.aspetjournals.org member 1), cell cycle regulation (e.g., never in mitosis gene a-related expressed kinase 6 and cyclin G 1 ) and protein transporting/trafficking (e.g., vesicle docking protein, sec1 family domain containing 1).
Analysis of all the bacteria-dependent genes using the Ingenuity System revealed impacted pathways ranked by p value (Table 2) . Highly impacted pathways included LPS/ interleukin (IL) 1-induced inhibition of retinoid X receptor (RXR) function, fatty acid metabolism, farnesoid X receptor (FXR)/RXR activation, and gene regulation via proliferatoractivated receptor (PPAR) ␣.
The bacteria-independent genes were also filtered by the criterion of degree of correlation with ALT. The genes highly correlated with ALT are shown in Table 3 . Many of these genes are related to inflammatory responses [e.g., intercellular adhesion molecule 1 (ICAM-1), IL1␤, tumor necrosis factor receptor superfamily member 1a (TNFRSF1a), prostaglandin E receptor 3] and to leukocyte transmigration and activation (e.g., ICAM-1, IL1␤).
Another interesting group comprised genes involved in oxidative stress, including superoxide dismutase (SOD) 2 and heme oxygenase 1 (HMOX1). Genes involved in cell death and cell cycle regulation were also in the list of genes for which expression is independent of bacteria. These genes include TNFRSF1a, tumor protein p53 (TP53), and STAT1. Several of these genes are known to be hypoxia-inducible. These include SOD2 (Scortegagna et al., 2003) , B-cell translocation gene 2 (Pacary et al., 2006) , STAT1 (West et al., 2004) , ICAM-1, and TP53 (Staib et al., 2005; Zhang et al., 2007) .
Analysis of all the bacteria-independent genes using the Ingenuity System also revealed impacted pathways ranked by p value (Table 4) . The results further suggest the involvement of oxidative stress and hypoxia signaling. Highly impacted pathways also included FXR/LXR activation, PPAR␣ signaling, and aryl hydrocarbon receptor signaling.
Lack of Role for PMNs in DCLF Hepatotoxicity. Because some of the genes for which expression was increased after DCLF treatment are involved in PMN trafficking and activation, liver PMN accumulation was evaluated 6 h after DCLF treatment. In livers of DCLF-treated rats, accumulation of large numbers of PMNs in the subcapsular region was evident (Fig. 4) . It is in these areas where the necrosis occurs. The PMN accumulation was markedly reduced by antibiotic treatment (Fig. 4) . To investigate the role of PMNs in hepatotoxicity, rats were pretreated with PMN antiserum. This antiserum abolished the subcapsular PMN accumulation in livers of DCLF-treated rats (Fig. 5) , but it did not significantly alter the serum ALT activity (Fig. 6) or the histopathology (data not shown).
Hypoxia after DCLF Treatment in Vivo. Because several genes altered by DCLF treatment are regulated by hypoxia, tissue hypoxia was evaluated 6 h after DCLF treatment using PIM adduct staining. DCLF induced a large increase in (Fig. 7) .
Effect of Hypoxia on DCLF-Induced Hepatocyte Death in Vitro. In vitro, hepatocytes incubated in an oxygen-replete atmosphere were not injured by DCLF up to 500 M (Fig. 8) . However, hypoxia (5% O 2 ) rendered hepatocytes sensitive to DCLF-induced cytotoxicity.
Discussion
Although DCLF is known to cause intestinal injury and to allow bacterial translocation to liver both in animal models and in human patients (Kim et al., 2005; Deng et al., 2006) , the contribution of intestinal bacteria to DCLF-mediated hepatotoxicity has not been well characterized. A previous study showed that bacteria/LPS interacted with a nontoxic dose of DCLF to induce liver injury in rats (Deng et al., 2006) . Thus, a goal of the present study was to examine the role of intestine-derived LPS/bacteria on DCLF-induced hepatotoxicity. In this model, liver injury as reflected by serum ALT activity did not develop until 4 h after treatment with a hepatotoxic dose of DCLF and was maximal by 6 h (X. Deng, M. Liguori, J. Waring, E. Blomme, P. Ganey, and R. Roth, unpublished data). In accordance, we chose to examine a time shortly after the beginning of liver injury (i.e., 6 h) because we expected gene expression changes to be pronounced at that time. At this time, there was substantial similarity in hepatic gene expression profiles between LPS treatment and treatment with a hepatotoxic DCLF dose (Fig.  3) . We did not examine earlier times in this study, but because gut sterilization protected from the liver injury at 6 h, we would anticipate fewer differences between sterilized and nonsterilized DCLF-treated rats at earlier times before injury onset.
To explore further the role of gut-derived bacteria in DCLF hepatotoxicity, gene expression profiles in livers from rats given a hepatotoxic dose of DCLF with or without antibiotic pretreatment were examined. It is interesting that hierarchical clustering could not distinguish antibiotic/DCLF-treated rats from those treated with Veh/DCLF. This suggested that gut sterilization with antibiotics altered the expression of a small number of genes in DCLF-treated rats. However, the antibiotics markedly reduced the hepatocellular injury resulting from DCLF, reflected by either serum ALT activity (Deng et al., 2006) or histopathology (Fig. 1) . This suggested that intestinal bacteria might cause injury by altering the expression of relatively few genes. Alternatively, bacteria might contribute to liver injury after DCLF treatment by a mechanism independent of changes in gene expression.
Clustering of gene expression profiles revealed high similarity between LPS-treated rats and rats given a hepatotoxic dose of DCLF (100 mg/kg) but little similarity to those given a nontoxic DCLF dose. In light of the previous result that LPS interacts with a nonhepatotoxic dose of DCLF (20 mg/ kg) to cause liver damage (Deng et al., 2006) , this finding suggested that LPS or inflammatory stimuli contribute to the liver injury from a hepatotoxic dose of DCLF. However, the mechanism of this contribution remains unknown.
The genes with expression altered by DCLF treatment (100 mg/kg) are of obvious potential mechanistic interest because liver injury occurred in these animals. Those genes can be classified into two groups: genes differentially expressed after DCLF treatment compared with antibiotic/ DCLF treatment and those similarly expressed after DCLF treatment and after antibiotic/DCLF treatment. The former group consists of genes that might contribute to liver injury through involvement of intestinal bacteria. The latter group represents genes for which either the expression was not changed due to intestinal bacteria, or the gene expression was intestinal bacteria-dependent, but the reduction of bacteria by antibiotics was not sufficient to exert effects on their expression. However, because the antibiotics almost abolished (97% reduction) hepatic Gram-negative bacteria after DCLF treatment (Deng et al., 2006) , the latter possibility seems less likely. Thus, the genes similarly expressed after DCLF treatment and after antibiotic/DCLF treatment more likely represent transcripts for which the expression is not due to intestinal bacteria, i.e., possibly resulting from a direct effect of DCLF or its metabolites.
In the group of genes for which expression was dependent on bacteria, those highly correlated with ALT were further categorized by their gene function. Some are known to be LPS-inducible, including fibrinogen and STAT3 (Lunz et al., . Genes encoding enzymes involved in fatty acid metabolism were reduced in expression after DCLF treatment. This change was not due to difference in food consumption because all rats remained fasted after the treatment until sacrifice. LPS is known to cause inhibition of fatty acid metabolism through nuclear transcription factors such as RXR, FXR, and PPAR␣ (Ghose et al., 2004; Kim et al., 2007) . Other than LPS-inducible genes, there were also genes involved in cell cycle regulation and protein transporting/trafficking. In the pathways identified by Ingenuity for bacteria-dependent genes, most of the genes are known to be LPSinducible, such as those in groups involved with LPS/IL-1-induced inhibition of RXR function, fatty acid metabolism, FXR/RXR activation, and gene regulation via PPAR␣. These altered pathways could lead to decreased fatty acid ␤-oxidation and increased fatty acid accumulation in liver. In other models of liver injury, fatty acid accumulation has been shown to be critical in the pathogenesis, possibly through increased oxidative stress (Purohit et al., 2004; CarmielHaggai et al., 2005) . However, whether or not fatty acid accumulation contributes to hepatocellular injury in DCLFtreated rats remains to be explored.
In the group of transcripts similarly expressed after DCLF treatment and antibiotic/DCLF treatment, those highly correlated with ALT were further categorized by gene function. As mentioned above, these genes represent those for which the expression was probably changed due to a direct DCLF effect rather than from involvement of intestinal bacteria. Many of these genes encode proteins that regulate inflammatory responses and leukocyte transmigration and activation. Thus, it seemed possible that bacteria or LPS induced the accumulation of leukocytes in the liver and that DCLF acted synergistically with bacteria or LPS to activate the leukocytes to contribute to the killing of hepatocytes. However, PMN depletion in DCLF-treated rats failed to reduce the liver injury. This suggests that bacteria/LPS contribute to liver injury in this model through a PMN-independent mechanism, perhaps through LPS-activated macrophages or other inflammatory mediators.
Other up-regulated genes of interest include those involved in oxidative stress, such as SOD2 and HMOX1. SOD2 is a mitochondrial antioxidant enzyme (Hu et al., 2005) , and HMOX1 is an acute phase response gene induced by oxidative stress (Takahashi et al., 2007) . The induction of these two genes suggested oxidative stress in the liver. This was further supported by the high ranking of oxidative stress pathways by the Ingenuity System after importation of all bacteria-independent genes. It is interesting that the results of Cantoni et al. (2003) suggest that oxidative stress might contribute to DCLF-induced hepatotoxicity in mice. In that study, hepatic damage was enhanced by the glutathionelowering agent, buthionine sulfoximine, but was not attenuated by the antioxidant N-acetylcysteine. This finding suggested that oxidative stress induced by DCLF might act with other deleterious signals to promote hepatotoxicity. These signals could be from bacteria or LPS translocated from the intestinal tract into the liver.
Genes involved in cell death and cell cycle regulation are also in the list of genes regulated independently of bacterial influence. These genes include TNFRSF1a, TP53, and STAT1. TNFRSF1a is responsible for TNF-induced apoptosis (Shen and Pervaiz, 2006) . TP53 is a tumor suppressor gene that not only regulates several apoptotic genes but also has a direct, proapoptotic role by interacting with B-cell leukemia/ lymphoma 2 family members in mitochondria (Hussain and Harris, 2006) . STAT1 is involved in inflammatory cytokineand reactive oxygen species-mediated apoptosis (West et al., 2004; Gorina et al., 2005) . Consistent with this is the observation that DCLF can induce hepatocyte apoptosis in vitro (Gómez-Lechón et al., 2003a) . It is possible that these DCLFinduced, proapoptotic stresses superimpose on the inflammatory stresses induced by bacteria/LPS to manifest hepatocellular injury.
Several other interesting pathways were highlighted that could contribute to liver injury. These include FXR/LXR activation, PPAR␣ signaling, and aryl hydrocarbon receptor signaling. It is interesting that FXR activation and PPAR␣ signaling are also identified in the group of genes for which expression was dependent on bacteria. These might be potential points of interaction between DCLF-induced bacteria/ LPS exposure and a direct toxic effect of DCLF on liver.
Numerous genes regulated by DCLF in a bacteria-independent manner are hypoxia-inducible. These include SOD2 (Scortegagna et al., 2003) , B-cell translocation gene 2 (Pacary et al., 2006) , STAT1 (West et al., 2004) , ICAM-1, and TP53 (Staib et al., 2005; Zhang et al., 2007) . Furthermore, Ingenuity System analysis revealed a high probability of involvement of hypoxia-inducible factor signaling. Hypoxia can di- The genes differentially expressed between antibiotic/DCLF and Veh/DCLF groups were imported into Ingenuity Pathway Analysis 5.5. Functional annotations were based on the Ingenuity System knowledge base. Ratio refers to the percentage of the total number of genes in a particular pathway found in the imported list of genes. The pathways reported by Ingenuity Pathway Analysis were ranked by p value, which illustrates the deviation of the observed number of genes for each pathway found in the imported list from the number expected to occur by chance.
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Ϫlog ( (Nagatomi et al., 1997; Lluis et al., 2005) . In addition, hypoxia potentiates the damaging effects of inflammatory mediators induced by LPS in vitro, such as macrophage-and neutrophil-derived cytotoxic factors (i.e., proteases, reactive oxygen species) (Luyendyk et al., 2005) . In vivo, hypoxia enhances the liver lesions caused by a large, hepatotoxic dose of LPS (Shibayama, 1987) . It is possible that hypoxia interacts with these inflammatory mediators induced by LPS to cause hepatocellular injury in vivo after treatment with DCLF. DCLF can kill hepatocytes directly after 24 h of exposure in vitro (Masubuchi et al., 2002) . However, the cytotoxicity was only observed at a large concentration (500 M) that might not be achieved in vivo. Furthermore, the time frame of the cell death was considerably longer than required in vivo (i.e., 6 h). This suggests that DCLF might need a second deleterious signal to manifest the killing of hepatocytes in vivo. Additional studies in vitro were pursued to explore this in light of the gene array findings. DCLF did not cause hepatocyte death after 8 h of exposure, even at the concentration (500 M) reported to kill hepatocytes at 24 h (Masubuchi et al., 2002) . However, hypoxia rendered hepatocytes sensitive to DCLF-induced cytotoxicity. For example, in a hypoxic environment, DCLF caused hepatocyte death even at a smaller concentration (250 M) and in a time frame similar to that required for hepatotoxicity in vivo. Because hypoxia occurred The genes similarly expressed between antibiotic/DCLF and Veh/DCLF groups were imported into Ingenuity Pathway Analysis 5.5. Functional annotations were based on the Ingenuity System knowledge base. Ratio refers to the percentage of the total number of genes in a particular pathway found in the imported list of genes. The pathways reported by Ingenuity Pathway Analysis were ranked by p value, which illustrates the deviation of the observed number of genes in one pathway of the Ingenuity System database found in the imported list from the number expected to occur by chance.
Pathway list
Ϫlog ( in livers of DCLF-treated rats (Fig. 7) , it might provide a second signal in vivo that acts synergistically with DCLF to kill hepatocytes. The mechanism by which hypoxia potentiates DCLF killing of hepatocytes is unknown, but both hypoxia and DCLF can induce mitochondrial injury and generation of reactive oxygen species (Masubuchi et al., 2002; Gómez-Lechón et al., 2003a; Lluis et al., 2005) . Either of these might be a potential interaction point between hypoxia and DCLF.
A large fraction of diclofenac glucuronide in humans is excreted by the kidney, whereas in rodents, the biliary route is more important. Although it is not clear that this difference in disposition influences hepatotoxicity, it is a factor that should be considered in extrapolating our findings to humans.
In summary, both bacteria-dependent and -independent changes in gene expression occurred after DCLF treatment in rats. Microarray analysis and additional studies revealed that bacteria/LPS contribute to DCLF hepatotoxicity in a PMN-independent manner. DCLF may interact with bacteria or LPS through inducing oxidative stress, apoptotic signaling, or changing fatty acid metabolism. Results in vitro suggest that hypoxia might provide a secondary signal that interacts with DCLF to kill hepatocytes, which is further supported by the observation that hypoxia occurred in vivo after DCLF treatment. 6 . Serum ALT activity after treatment with PMN antiserum. Rats were treated as described in Fig. 8 , and serum ALT activity was evaluated 6 h after DCLF treatment; n ϭ 5-6. Values are not significantly different. Fig. 7 . PIM adduct staining after DCLF treatment. Rats were treated with DCLF (100 mg/kg), and PIM adduct staining was evaluated 6 h later; n ϭ 5-6. ‫,ء‬ significantly different from Veh treatment group. 
